Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe - Concepedia

Concepedia

Publication | Open Access

Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe

DOI Full Paper Access

31

Citations

27

References

2019

Year

Carmen Alcalá, Francisco Gascón, Francisco Pérez‐Miralles, J. A. Domínguez, Sara Gil‐Perotín, Bonaventura Casanova

Journal of Neurology

Neurological ProgressFingolimod WithdrawalNeurologyMultiple SclerosisMedicine

References

	Year	Citations

Page 1